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Although hexavalent chromium is well established as a human carcinogen by the inhalation
route, there are significant uncertainties in the quantitative estimation of cancer risk. One of
the important uncertainties is the assumption that the carcinogenic potency, determined under
conditions ofoccupational exposure where most workers were cigarette smokers, applies to the
nonsmoking individual in the general population. There is substantial evidence that carcinoge-
nicity is a function ofthe rate of cell turnover in the target tissue. The chromate worker would
be expected to have a relatively high rate of cell proliferation in the bronchial mucosa due to
airborne irritants and smoking. The potency of chromium might therefore be relatively high
under conditions ofoccupational exposure. This problem in quantitative risk assessment applies
equally well to another important indoor pollutant, radon.
From the standpoint ofthe hazard evaluation portion
of the carcinogen risk assessment process, we are bet-
ter off in the case of chromium than with most of the
agents that have had to be dealt with by regulatory
agencies. Chromium is thoroughly established as a hu-
man carcinogen and is regarded as such by the Interna-
tional Agency for Research on Cancer (1), the Environ-
mental Protection Agency (2), and the World Health
Organization (3). Thisjudgment is based on over 40 epi-
demiological studies. The hexavalent form ofchromium
has also been established as a carcinogen in animals (4),
and this form ofchromium is also genotoxic in a variety
of short-term genetic bioassays (5,6). There is general
acceptance that it is only the inhaled form ofhexavalent
chromium that is carcinogenic, and it affects only the
lung; ingested chromium of any form does not consti-
tute a cancer hazard. So, there is no question that in-
haled hexavalent chromium should be treated as a hu-
man carcinogen.
From the standpoint ofquantitative risk assessment,
there are the same uncertainties in the character ofthe
dose-response relationships at low levels of exposure
that are common to all other carcinogens. Chromium
does have some quantitative exposure data in relation
to cancer response. Thus, the uncertainties in the ex-
trapolation ofanimal responses to humans that apply to
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agents whose evidence for carcinogenicity comes only
from animal studies is less important for chromium. A
significant issue is the applicability of lung cancer re-
sponses that occur in the occupational setting to the
estimation of risks from exposure of the general popu-
lation in their homes. The problem is comparable to the
situation with radon gas in homes. Like chromium, the
evidence for the carcinogenicity of radon for the lung
currently comes only from occupational groups, namely,
uranium miners. Radon is also an unequivocal lung
carcinogen for humans, based on a number ofepidemio-
logical studies (7). Radon is carcinogenic for the lung in
animals, and there is evidence for the genotoxicity of
radon from a variety ofgenetic bioassays.
The major uncertainties in extrapolating occupational
lung cancer responses in worker populations to indoor
exposure ofthe general population are those related to
age, sex, and cigarette smoking. Men constituted the
entire worker populations in the uranium mines and
the chromate industry, and most were cigarette smok-
ers. There are very few data comparing the lung cancer
responses to carcinogens in meh and women, but given
the sharply rising incidence of lung cancer in women
associated with the corresponding increase in the num-
ber of women who are smokers, the differences in re-
sponsiveness between men and women are probably
not large.
There is one possibly major factor that differentiates
the smoking miner or chromate worker from a non-
smoking member of the general population and that is
the rate of cell proliferation ofthe epithelial cells in the
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mucosa ofthe larger bronchi where most ofthe cancers
arise. These cells are the targets for cancer develop-
ment from both radon and chromium. The epithelial cells
of the bronchial mucosa have one ofthe lowest rates of
turnover in any ofthe body tissues (8). It is well estab-
lished that cell proliferation is an essential factor in the
carcinogenic process. Cells in tissue culture require
several divisions after exposure to ionizing radiation to
fix neoplastic transformation (9). Benzo[a]pyrene ad-
ministered by intratracheal injection does not produce
tracheal tumors unless the trachea is traumatized by
the injection needle, thereby inducing cell proliferation
(10). Similarly, the induction of bronchiolar tumors in
the hamster lung by the instillation ofradioactive polo-
nium in the lung is markedly enhanced by subsequent
injections of saline, which induce cell proliferation (11).
In another proliferatively static tissue, the liver, ure-
thane administered to the adult mouse does not induce
tumors unless there is stimulation of cell proliferation
by partial hepatectomy (12). Very young animals whose
livers are proliferating relatively rapidly as part of the
growth process are much more susceptible to tumor
formation than adult rats (13). Similarly, tumor induc-
tion in the rapidly growing newborn rat by ionizing
radiation is more effective than in the adolescent rat by
a factor ofthree (14). Tumor induction in the nasal mu-
cosa of the rat by the inhalation of formaldehyde does
not occur at doses that do not increase the normally
very low level of cell proliferation in that tissue (15).
Wounding of the mouse skin after initiation by a small
dose of carcinogen, a procedure which markedly in-
creases cell proliferation, is an effective promoting factor
(16). A characteristic feature ofpromoting agents is their
ability to increase the level ofcell proliferation (17). It is
possible that a measure of effective carcinogen dose
would be the target tissue dose at the time ofcell repli-
cation, and hence the effective carcinogen dose would
be proportional to cell replication rates for equal target
cell carcinogen doses.
Chronic inhalation ofcigarette smoke, in common with
otherirritants, causes the respiratory mucosa to change
from its normal relatively nonproliferative secretory and
ciliated pattern to one of squamous metaplasia, which
has a higher than normal proliferative rate (18). The
normally heavy atmospheric loading ofirritating dusts,
gases, and fumes in uranium mines and chromate plants
would be expected to cause squamous metaplasia even
in the absence of cigarette smoking. Hence, a possibly
important difference between the cigarette-smoking
chromate worker and uranium miner would be the
higher proliferation rates in the bronchial mucosa than
in the nonsmoking member ofthe general-adult popula-
tion who does not work in irritant atmospheres. For
the latter population, exposure to indoor pollution from
chromium and radon night be less hazardous than in
uranium miners and chromate workers for equivalent
exposure. In fact, the risks experienced by uranium
miners and chromate workers may be more relevant to
the growing individual who has a relatively high prolif-
eration rate in the bronchial mucosa.
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